Corrigendum to “5-Bromo-3,4-dihydroxybenzaldehyde attenuates endothelial cells injury from high glucose-induced damage” [Biomed. Pharmacother. 155 (2022) 113793] - 27/04/24
Doi : 10.1016/j.biopha.2024.116498
Qionghua Wang a, Kepeng Ou b, Chunqin Zeng a, Yanhong Fang a, ⁎ 
a Chongqing University Jiangjin Hospital, School of Medicine, Chongqing University, Chongqing, China
b College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing, China
⁎Correspondence to: No. 725, Jiangzhou Avenue, Dingshan Street, Jiangjin District, Chongqing 402260, China.No. 725, Jiangzhou Avenue, Dingshan Street, Jiangjin DistrictChongqing402260China
El texto completo de este artículo está disponible en PDF.
© 2024
The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 174
Artículo 116498- mai 2024 Regresar al número
Artículo precedente
- Response to antifibrotic therapy and decrease of circulating BAG3 protein levels in systemic sclerosis patients with reduced forced vital capacity
- Margot De Marco, Anna Basile, Anna Lisa Cammarota, Claudia Iannone, Antonia Falco, Liberato Marzullo, Alessandra Rosati, Roberto Caporali, Maria Caterina Turco, Nicoletta Del Papa
- Corrigendum to “β-Asarone suppresses Wnt/β-catenin signaling to reduce viability, inhibit migration/invasion/adhesion and induce mitochondria-related apoptosis in lung cancer cells” [Biomed. Pharmacother. 106 (2018) 821–830]
- Tao-Li Wang, Chen-Sheng Ouyang, Li-Zhu Lin
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?